Skip to content

Construction of artificial intelligence-assisted recognition system for digestive tract early cancer based on energy spectrum CT and exploration of mechanism

Construction of artificial intelligence-assisted recognition system for digestive tract early cancer based on energy spectrum CT and exploration of mechanism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075749
Enrollment
Unknown
Registered
2023-09-14
Start date
2022-01-29
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract early cancer

Interventions

Index test:Multi-energy spectrum CT, Energy Spectrum Computerized Tomography Artificial Intelligence model (EnSpeAI),

Sponsors

Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with digestive tract early cancer by pathological biopsy; (2) There was no history of radiotherapy or chemotherapy before energy spectrum CT examination; (3) Sign the inspection consent before the inspection; (4) The image quality of energy spectrum CT examination is satisfactory, and the amount of data meets the requirements of image analysis

Exclusion criteria

Exclusion criteria: (1) Refuse to cooperate with the inspection; (2) those who have serious underlying diseases or complicated with esophago-related diseases, and cannot cooperate well with examination, such as severe upper gastrointestinal bleeding, severe esophageal obstruction, esophageal perforation, etc.; (3) pregnant or breast-feeding women; (4) lack of picture information of upper gastrointestinal endoscopy; (5) The image quality of energy spectrum CT examination is poor or the information obtained is incomplete; (6) The lesion size is not enough to outline the Region of Interest (ROI). (7) allergic to iodine contrast media, or complicated with thyroid disease, cannot use iodine contrast media;

Design outcomes

Primary

MeasureTime frame
ROC curve;Mean values of monochromatic CT values at 40-140 kev;

Secondary

MeasureTime frame
Sensitivity;Specificity ;Accuracy;Standard deviation of monochromatic CT values at 40-140 kev;Mean values of Effective-Z;Standard deviation of Effective-Z;Mean values of base matter pair density;Standard deviation of base matter pair density;Area Under The Curve;

Countries

China

Contacts

Public ContactKai Deng

Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University

dengkai@wchscu.cn+86 189 8060 6867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026